Obesity and Its Relationship to Infertility in Men and Women

Obstetrics and Gynecology Clinics of North America

Volumn 36, Issue 2, 2009, Pages 333-346

  Loret de Mola, J Ricardo ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Carol Jo Vecchie Women's Health   (United States)

Author keywords

Infertility female; Infertility male; Metabolic syndrome; Obesity; PCOS; Reproduction

Indexed keywords

GONADOTROPIN;

ENDOCRINE FUNCTION; FEMALE INFERTILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LIVE BIRTH; MALE INFERTILITY; MENSTRUATION; NOMOGRAM; OBESITY; OUTCOME ASSESSMENT; OVULATION; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEMEN ANALYSIS; WEIGHT REDUCTION;

FEMALE; HUMANS; INFERTILITY; MALE; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTION; WEIGHT LOSS;

EID: 66149160246     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2009.03.002     Document Type: Review

References (104)

1. James P.T. Obesity: the worldwide epidemic. Clin Dermatol 22 (2004) 276-280
2. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
3. Gambineri A., Pelusi C., Vicennati V., et al. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26 (2002) 883-896
4. Ford E.S. Prevalence of the metabolic syndrome in US population. Endocrinol Metab Clin North Am 33 (2004) 333-350
5. Linné Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 5 (2004) 137-143
6. Pasquali R., Pelusi C., Genghini S., et al. Obesity and reproductive disorders in women. Hum Reprod Update 9 (2003) 359-372
7. Reddy U.M., Wapner R.J., Rebar R.W., et al. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 109 (2007) 967-977
8. Jimenez Torres M., Campoy Folgoso C., Canabate Reche F., et al. Organochlorine pesticides in serum and adipose tissue of pregnant women in southern Spain giving birth by cesarean section. Sci Total Environ 372 (2006) 32-38
9. Munoz-de-Toro M., Beldomenico H.R., Garcia S.R., et al. Organochlorine levels in adipose tissue of women from a littoral region of Argentina. Environ Res 102 (2006) 107-112
10. Nguyen R., Wilcox A., Skjaerven R., et al. Men's body mass index and infertility. Hum Reprod 17 (2007) 2488-2493
11. Magnusdottir E.V., Thorsteinsson T., Thorsteinsdottir S., et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod 20 (2005) 208-215
12. Hanafy S., Halawa F.A., Mostafa T., et al. Serum leptin correlates in infertile oligozoospermic males. Andrologia 39 (2007) 177-180
13. Zorn B., Osredkar J., Meden-Vrtovec H., et al. Leptin levels in infertile male patients is correlated with inhibin B, testosterone and SHBG but not with sperm characteristics. Int J Androl 30 (2007) 439-444
14. Castilla J.A., Alvarez C., Aguilar J., et al. Influence of analytical and biological variation on the clinical interpretation of seminal parameters. Hum Reprod 21 (2006) 847-851
15. Hammoud A.O., Gibson M., Peterson C.M., et al. Effect of sperm preparation techniques by density gradient on intra-individual variation of sperm motility. Arch Androl 53 (2007) 349-351
16. Keel B.A. Within- and between-subject variation in semen parameters in infertile men and normal semen donors. Fertil Steril 85 (2006) 128-134
17. Azziz J.R., Sanchez L.A., Knochenhauer E.S., et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89 (2004) 453-462
18. Bonde J.P., Ernst E., Jensen T.K., et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 352 (1998) 1172-1177
19. Slama R., Eustache F., Ducot B., et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 17 (2002) 503-515
20. Guzick D.S., Overstreet J.W., Factor-Litvak P., et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 345 (2001) 1388-1393
21. Jensen T.K., Andersson A.M., Jorgensen N., et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 82 (2004) 863-870
22. Fejes I., Koloszar S., Szollosi J., et al. Is semen quality affected by male body fat distribution?. Andrologia 37 (2005) 155-159
23. Kort H.I., Massey J.B., Elsner C.W., et al. Impact of body mass index values on sperm quantity and quality. J Androl 27 (2006) 450-452
24. Bacon C.G., Mittleman M.A., Kawachi I., et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139 (2003) 161-168
25. Sullivan M.E., Thompson C.S., Dashwood M.R., et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?. Cardiovasc Res 43 (1999) 658-665
26. Mieusset R., Bujan L.E., Massat G., et al. Inconstant ascending testis as a potential risk factor for spermatogenesis in infertile men with no history of cryptorchism. Hum Reprod 12 (1997) 974-979
27. Shafik A., and Olfat S. Lipectomy in the treatment of scrotal lipomatosis. Br J Urol 53 (1981) 55-61
28. Giagulli V.A., Kaufman J.M., and Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 79 (1994) 997-1000
29. Tchernof A., Despres J.P., Belanger A., et al. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 44 (1995) 513-519
30. Schneider G., Kirschner M.A., Berkowitz R., et al. Increased estrogen production in obese men. J Clin Endocrinol Metab 48 (1979) 633-638
31. Goyal H.O., Robateau A., Braden T.D., et al. Neonatal estrogen exposure of male rats alters reproductive functions at adulthood. Biol Reprod 68 (2003) 2081-2091
32. Akingbemi B.T. Estrogen regulation of testicular function. Reprod Biol Endocrinol 3 (2005) 51
33. de Boer H., Verschoor L., Ruinemans-Koerts J., et al. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 7 (2005) 211-215
34. Pavlovich C.P., King P., Goldstein M., et al. Evidence of a treatable endocrinopathy in infertile men. J Urol 165 (2001) 837-841
35. Kumanov P., Nandipati K., Tomova A., et al. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril 86 (2006) 332-338
36. Winters S.J., Wang C., Abdelrahaman E., et al. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?. J Androl 27 (2006) 560-564
37. Cortet-Rudelli C., Pigny P., Decanter C., et al. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 77 (2002) 281-287
38. De Pergola G., Maldera S., Tartagni M., et al. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring) 14 (2006) 1954-1960
39. Stellato R.K., Feldman H.A., Hamdy O., et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23 (2000) 490-494
40. Luboshitzky R., Lavie L., Shen-Orr Z., et al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res 13 (2005) 780-786
41. Luboshitzky R., Zabari Z., Shen-Orr Z., et al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 86 (2001) 1134-1139
42. Blank D.M., Clark R.V., Heymsfield S.B., et al. Endogenous opioids and hypogonadism in human obesity. Brain Res Bull 34 (1994) 571-574
43. Farooqi I.S., Wangensteen T., Collins S., et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356 (2007) 237-247
44. Galtier-Dereure F., Pujol P., Dewailly D., et al. Choice of stimulation in polycystic ovarian syndrome: the influence of obesity. Hum Reprod 12 Suppl 1 (1997) 88-96
45. Lobo R.A., Gysler M., March C.M., et al. Clinical and laboratory predictors of clomiphene response. Fertil Steril 37 (1982) 168-174
46. Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 52 (1989) 703-725
47. Abbott D.H., Dumesic D.A., and Franks S. Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol 174 (2002) 1-5
48. Eisner J.R., Dumesic D.A., Kemnitz J.W., et al. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 85 (2000) 1206-1210
49. Rexrode K.M., Carey V.J., Hennekens C.H., et al. Abdominal adiposity and coronary heart disease in women. JAMA 280 (1998) 1843-1848
50. Poretsky L., Cataldo N.A., Rosenwaks Z., et al. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20 (1999) 535-582
51. Agarwal A., Gupta S., and Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3 (2005) 28-49
52. Agarwal S.K., Vogel K., Weitsman S.R., et al. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 84 (1999) 1072-1076
53. Duggal P.S., Van Der Hoek K.H., Milner C.R., et al. The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology 141 (2000) 1971-1976
54. Gammon C.M., Freeman Jr. M., Xie W., et al. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 146 (2005) 4491-4499
55. Murphy L.L., Steger R.W., Smith M.S., et al. Effects of D9-tetrahydrocannabinol,cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 52 (1990) 316-321
56. Murphy L.L., Munoz R.M., Adrian B.A., et al. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 5 (1998) 432-446
57. Catalano P.M. Management of obesity in pregnancy. Obstet Gynecol 109 (2007) 419-433
58. Yu C.K.H., Teoh T.G., and Robinson S. Obesity in pregnancy. BJOG 113 (2006) 1117-1125
59. Ramsay J.E., Greer I., and Sattar N. Obesity and reproduction. BMJ 333 (2006) 1159-1162
60. Lashen H., Fear K., and Sturdee D.W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 19 (2004) 1644-1646
61. Fedorcsak P., Storeng R., Dale P.O., et al. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 79 (2000) 43-48
62. Wang J.X., Davies M.J., and Norman R.J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 16 (2001) 2606-2609
63. Heijnen E.M.E.W., Eijkemans M.J.C., Hughes E.G., et al. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12 (2006) 13-21
64. Craig L.B., Ke R.W., and Kutteh W.H. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 78 (2002) 487-490
65. Tian L., Shen H., Lu Q., et al. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab 92 (2007) 1430-1433
66. Cnattingius S., Bergstrom R., Lipworth L., et al. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 338 (1998) 147-152
67. Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103 (2004) 219-224
68. Watkins M.L., Rasmussen S.A., Honein M.A., et al. Maternal obesity and risk for birth defects. Pediatrics 111 (2003) 1152-1158
69. Cedergren M., and Kallen B. Maternal obesity and the risk for orofacial clefts in the offspring. Cleft Palate Craniofac J 42 (2005) 367-371
70. Cedergren M.I., and Kallen B.A. Maternal obesity and infant heart defects. Obes Res 11 (2003) 1065-1071
71. Callaway L.K., Prins J.B., Chang A.M., et al. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 184 (2006) 56-59
72. Hendler I., Blackwell S.C., Bujold E., et al. Suboptimal second-trimester ultrasonographic visualization of the fetal heart in obese women: should we repeat the examination?. J Ultrasound Med 24 (2005) 1205-1209
73. Hendler I., Blackwell S.C., Bujold E., et al. The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures. Int J Obes Relat Metab Disord 28 (2004) 1607-1611
74. Smith G.C.S., Shah I., Pell J.P., et al. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 97 (2007) 157-162
75. Dokras A., Baredziak L., Blaine J., et al. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol 108 (2006) 61-69
76. Kaukua J., Pekkarinen T., Sane T., et al. Sex hormones and sexual function in obese men losing weight. Obes Res 11 (2003) 689-694
77. Bastounis E.A., Karayiannakis A.J., Syrigos K., et al. Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. Eur Surg Res 30 (1998) 43-47
78. Despres J.-P., Lemieux I., and Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322 (2001) 716-720
79. Huber-Buchholz M.M., Carey D.G.P., and Norman R.J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84 (1999) 1470-1474
80. Moran L.J., Noakes M., Clifton P.M., et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 812-819
81. Wadden T.A., Berkowitz R.I., Womble L.G., et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353 (2005) 2111-2120
82. Hoeger K.M., Kochman L., Wixom N., et al. A randomized, 48-week, placebo controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 82 (2004) 421-429
83. Tang T., Glanville J., Hayden C.J., et al. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21 (2006) 80-89
84. Teitelman M., Grotegut C.A., Williams N.N., et al. The impact of bariatric surgery on menstrual patterns. Obes Surg 16 (2006) 1457-1463
85. Deitel M., Stone E., Kassam H.A., et al. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 7 (1988) 147-153
86. Dixon J.B., Dixon M.E., and O'Brien P.E. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 106 (2005) 965-972
87. Moll E., Bossuyt P.M.M., Korevaar J.C., et al. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomized double blind clinical trial. BMJ 332 (2006) 1485-1490
88. Al-Azemi M., Omu F.E., and Omu A.E. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 270 (2004) 205-210
89. Legro R.S., Myers E.R., Barnhart H.X., et al. The pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86 (2006) 914-933
90. Beck J.I., Boothroyd C., Proctor M., et al. Oral antioestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 1 (2005) CD002249
91. Hammond M.G., Halme J.K., and Talbert L.M. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 62 (1983) 196-202
92. Imani B., Eijkemans M.J.C., te Velde E.R., et al. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622
93. Legro R.S. Pregnancy considerations in women with polycystic ovary syndrome. Clin Obstet Gynecol 50 (2007) 295-304
94. Legro R.S., Barnhart H.X., Schlaff W.D., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 551-566
95. Siebert T.I., Kruger T.F., Steyn D.W., et al. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril 86 (2006) 1432-1437
96. Harborne L.R., Sattar N., Norman J.E., et al. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab 90 (2005) 4593-4598
97. Douchi T., Oki T., Yamasaki H., et al. Body fat patterning in polycystic ovary syndrome women as a predictor of the response to clomiphene. Acta Obstet Gynecol Scand 83 (2004) 838-841
98. Mulders A.G.M.G.J., Laven J.S.E., Eijkemans M.J.C., et al. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update 9 (2003) 429-449
99. Laven J.S., Mulders A.G., Visser J.A., et al. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89 (2004) 318-323
100. Balen A.H., Platteau P., Andersen A.N., et al. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 113 (2006) 1195-1202
101. Dechaud H., Anahory T., Reyftmann L., et al. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 127 (2006) 88-93
102. Ku S.Y., Kim S.D., Jee B.C., et al. Clinical efficacy of body mass index as predictor of in vitro fertilization and embryo transfer outcomes. J Korean Med Sci 21 (2006) 300-303
103. Fedorcsak P., Dale P.O., Storeng R., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 (2004) 2523-2528
104. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89 3 (2008) 505-522